Anbiping

Anbiping focuses on R&D, production, and service of pathological diagnostic products.

Last Funding Type: Series B
Last Funding Money Raised: ¥20M
Industries: Biotechnology,Health Care,Health Diagnostics,Manufacturing,Medical,Pharmaceutical
Founded date: Jul 6, 2005
Number Of Employee: 251 - 500
Operating Status: Active

Number of Funding Rounds

Total Funding Amount

4

¥63M

Anbiping has raised a total of ¥63M in funding over 2 rounds. Their latest funding was raised on Jun 21, 2017 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 21, 2017	Series C	¥30M	1	Qushui Aiwei	—	Detail
Dec 26, 2013	Series B	¥20M	2	—	—	Detail
May 29, 2013	Series A	¥10M	2	—	—	Detail
Sep 20, 2012	Angel	¥3M	2	—	—	Detail

Number of Lead Investors

Number of Investors

1

7

Anbiping is funded by 7 investors. Qushui Aiwei and Weishi Touzi are the most recent investors.